Get the Stockscreener App
147.66
0.23%
-0.34
Pre-market:
147.35
-0.31
-0.21%
Transmedics Group Inc stock is traded at $147.66, with a volume of 701.51K.
It is down -0.23% in the last 24 hours and up +13.26% over the past month.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
See More
Previous Close:
$148.00
Open:
$149.14
24h Volume:
701.51K
Relative Volume:
0.92
Market Cap:
$5.07B
Revenue:
$531.29M
Net Income/Loss:
$71.66M
P/E Ratio:
76.36
EPS:
1.9338
Net Cash Flow:
$17.35M
1W Performance:
+11.99%
1M Performance:
+13.26%
6M Performance:
+41.91%
1Y Performance:
+113.66%
1-Day Range:
$145.91
$151.00
1-Week Range:
$128.00
$151.00
52-Week Range:
$62.07
$156.00
Transmedics Group Inc Stock (TMDX) Company Profile
Name
Transmedics Group Inc
Sector
Industry
Phone
(978) 552-0900
Address
200 MINUTEMAN ROAD, ANDOVER, MA
Compare TMDX vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMDX
Transmedics Group Inc
|
147.66 | 5.08B | 531.29M | 71.66M | 17.35M | 1.9338 |
|
ABT
Abbott Laboratories
|
113.10 | 197.42B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
381.89 | 147.18B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
95.60 | 124.16B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
72.21 | 109.58B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.22 | 49.49B | 6.07B | 1.06B | 1.34B | 1.8063 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-23-25 | Upgrade | Needham | Hold → Buy |
| Oct-13-25 | Initiated | Jefferies | Buy |
| Sep-16-25 | Initiated | Evercore ISI | Outperform |
| Sep-04-25 | Initiated | Stifel | Hold |
| Dec-17-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-22-24 | Downgrade | Needham | Buy → Hold |
| Oct-29-24 | Reiterated | Needham | Buy |
| Oct-29-24 | Reiterated | Oppenheimer | Outperform |
| Sep-24-24 | Initiated | Robert W. Baird | Outperform |
| Aug-21-24 | Initiated | Needham | Buy |
| Jun-06-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-04-24 | Initiated | Stephens | Overweight |
| Mar-28-24 | Initiated | Piper Sandler | Overweight |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Aug-02-22 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-08-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-07-20 | Initiated | Oppenheimer | Outperform |
| May-28-19 | Initiated | Canaccord Genuity | Buy |
| May-28-19 | Initiated | Cowen | Outperform |
| May-28-19 | Initiated | JP Morgan | Overweight |
| May-28-19 | Initiated | Morgan Stanley | Equal-Weight |
View All
Transmedics Group Inc Stock (TMDX) Latest News
Anil Ranganath Sells 864 Shares of TransMedics Group (NASDAQ:TMDX) Stock - MarketBeat
Insider Selling: TransMedics Group (NASDAQ:TMDX) CFO Sells 375 Shares of Stock - MarketBeat
TransMedics group CFO Hernandez sells shares worth $1.12 million - Investing.com
Nicholas Corcoran Sells 2,966 Shares of TransMedics Group (NASDAQ:TMDX) Stock - MarketBeat
TransMedics Group (NASDAQ:TMDX) CFO Sells $1,065,211.56 in Stock - MarketBeat
TransMedics group CFO Hernandez sells shares worth $1.12 million By Investing.com - Investing.com UK
TransMedics Group, Inc. $TMDX Shares Acquired by DNB Asset Management AS - MarketBeat
Why TransMedics Group (TMDX) Is Up 9.2% After Strong 2025 Results And 2026 Outlook - simplywall.st
TransMedics Group, Inc. (TMDX) Stock Analysis: Strong Growth with a 54.24% Return on Equity - DirectorsTalk Interviews
TransMedics Group, Inc. $TMDX Shares Acquired by Citigroup Inc. - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Connect - ACCESS Newswire
TD Cowen Health Care Conference - marketscreener.com
Got $5,000? TransMedics Could Be a High‑Tech Organ Transplant Moonshot - Yahoo Finance
TransMedics Stock Soars After Beating Revenue Expectations and Raising Guidance - timothysykes.com
Wall Street Zen Downgrades TransMedics Group (NASDAQ:TMDX) to Hold - MarketBeat
TransMedics Shares Surge Amid Strong Q4 Financial Performance - StocksToTrade
TransMedics’ Shares Surge on Strong Q4 Results and Price Target Raises - StocksToTrade
TransMedics Stock Surges as Analysts Raise Price Targets Amid Strong Earnings - timothysykes.com
TransMedics Stock Surges After Outstanding Q4 Earnings and Strategic Expansion Plans - StocksToTrade
TransMedics Group (NASDAQ:TMDX) Shares Up 5.9%What's Next? - MarketBeat
Vanguard Group Inc. Buys 9,650 Shares of TransMedics Group, Inc. $TMDX - MarketBeat
TransMedics provides information on impact of release of valuation allowance on deferred tax assets on previously reported quarterly results - marketscreener.com
TransMedics clarifies Q4 tax benefit impact on earnings - Investing.com
TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial Results - PR Newswire
Analysts’ Top Healthcare Picks: Vaxcyte (PCVX), TransMedics Group (TMDX) - The Globe and Mail
TransMedics Group, Inc. (TMDX): A bull case theory - MSN
Is It Too Late To Consider TransMedics Group (TMDX) After Its 79% One-Year Surge? - Yahoo Finance
TransMedics Group, Inc. (NASDAQ:TMDX) Q4 2025 Earnings Call Transcript - Insider Monkey
TransMedics Group Stock Plunges 4.3% as $350M Surge Propels It to 390th Most Traded Amid Mystery - Bitget
JP Morgan Maintains Neutral Rating for TMDX with Raised Price Ta - GuruFocus
Needham raises TransMedics stock price target to $174 on beat By Investing.com - Investing.com Canada
Oppenheimer Raises Price Target for TransMedics Group (TMDX) to - GuruFocus
JPMorgan Chase & Co. Issues Positive Forecast for TransMedics Group (NASDAQ:TMDX) Stock Price - MarketBeat
TransMedics Group (NASDAQ:TMDX) Stock Price Expected to Rise, Oppenheimer Analyst Says - MarketBeat
TMDX Shares Climb After Q4 Earnings and Revenue Surpass Expectations - Bitget
TMDX Stock Rises as Q4 Earnings & Revenues Beat Estimates - Finviz
TransMedics Group, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
TMDX Analyst Rating Update: Piper Sandler Raises Price Target | - GuruFocus
Piper Sandler Forecasts Strong Price Appreciation for TransMedics Group (NASDAQ:TMDX) Stock - MarketBeat
Evercore ISI Group Raises Price Target for TransMedics Group (TM - GuruFocus
Oppenheimer Adjusts Price Target on TransMedics to $175 From $150, Maintains Outperform Rating - marketscreener.com
Needham Raises Price Target on TransMedics Group to $174 From $166, Keeps Buy Rating - marketscreener.com
TransMedics revenue up 32% to USD 160.8M in Q4 2025 - Medical Buyer
TransMedics Group (NASDAQ:TMDX) Stock Price Expected to Rise, Needham & Company LLC Analyst Says - MarketBeat
Needham raises TransMedics stock price target to $174 on beat - Investing.com
A Glimpse Into The Expert Outlook On TransMedics Group Through 4 Analysts - Benzinga
TMDX: Needham Raises Price Target to $174, Maintains Buy Rating - GuruFocus
TransMedics (TMDX) stock jumps 7% premarket after earnings, 2026 revenue outlook - TechStock²
TransMedics Group, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:TMDX) 2026-02-25 - Seeking Alpha
TransMedics Group (TMDX) Reports Strong Q4 2025 Growth - GuruFocus
TransMedics Reports Strong Q4 2025 Earnings with Significant Growth - Intellectia AI
Transmedics Group Inc Stock (TMDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.27%
1.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):